En vivo
10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com AustraliaIlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - IlluminaFierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave risesFierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS datasetFierceBiotechRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trialsLonza NewsProject Hope Foundation receives $50K donation from Lonza Capsugel - Greenville JournalFierceBiotechPulnovo Medical scores $100M in finance round led by MedtronicIlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - IlluminaLonza NewsLonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWSDandong Aolong Radiative Instrument Group Co.,LtdWho Are the Top Competitors in the Bulk Petroleum and Chemical Storage Market Today - Weekly VoiceDandong Aolong Radiative Instrument Group Co.,LtdCompetitive Developments in the Industrial X-Ray Market: Strategies to Watch - Weekly Voice
FierceBiotech 23 feb 2026

MoonLake's phase 2 arthritis win kicks off pivotal year for IL-17 nanobody

MoonLake's phase 2 arthritis win kicks off pivotal year for IL-17 nanobody

Original
Contenido no disponible. Consulta la fuente original.